ES2301293B1 - USE OF MICOSPORINE TYPE AMINO ACID (PORPHYRA 334) AS AN ANTIOXIDANT. - Google Patents
USE OF MICOSPORINE TYPE AMINO ACID (PORPHYRA 334) AS AN ANTIOXIDANT. Download PDFInfo
- Publication number
- ES2301293B1 ES2301293B1 ES200502161A ES200502161A ES2301293B1 ES 2301293 B1 ES2301293 B1 ES 2301293B1 ES 200502161 A ES200502161 A ES 200502161A ES 200502161 A ES200502161 A ES 200502161A ES 2301293 B1 ES2301293 B1 ES 2301293B1
- Authority
- ES
- Spain
- Prior art keywords
- porphyra
- antioxidant
- amino acid
- isolated
- leucosticta
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 150000001413 amino acids Chemical class 0.000 title claims abstract description 16
- VIZAVBQHHMQOQF-KKUJBODISA-N porphyra-334 Chemical compound COC1=C(NCC(O)=O)CC(O)(CO)C\C1=N\[C@H]([C@H](C)O)C(O)=O VIZAVBQHHMQOQF-KKUJBODISA-N 0.000 title claims description 19
- VIZAVBQHHMQOQF-UHFFFAOYSA-N porphyra-334 Natural products COC1=C(CC(O)(CO)C/C/1=NC(C(C)O)C(=O)O)NCC(=O)O VIZAVBQHHMQOQF-UHFFFAOYSA-N 0.000 title claims description 19
- 230000003078 antioxidant effect Effects 0.000 title description 36
- 239000003963 antioxidant agent Substances 0.000 title description 26
- 238000000034 method Methods 0.000 claims abstract description 18
- 230000008569 process Effects 0.000 claims abstract description 8
- 238000002360 preparation method Methods 0.000 claims abstract description 7
- 230000000711 cancerogenic effect Effects 0.000 claims abstract description 6
- 231100000315 carcinogenic Toxicity 0.000 claims abstract description 6
- 230000002265 prevention Effects 0.000 claims abstract description 6
- 241001474374 Blennius Species 0.000 claims abstract description 5
- 235000013376 functional food Nutrition 0.000 claims abstract description 5
- 239000002417 nutraceutical Substances 0.000 claims abstract description 5
- 235000021436 nutraceutical agent Nutrition 0.000 claims abstract description 5
- 241001491795 Pyropia leucosticta Species 0.000 claims description 19
- 239000000284 extract Substances 0.000 claims description 15
- 239000000047 product Substances 0.000 claims description 9
- VVTDHOIRNPCGTH-UHFFFAOYSA-N Mycosporin 1 Natural products COC1=C(NC(CO)CO)CC(O)(CO)CC1=O VVTDHOIRNPCGTH-UHFFFAOYSA-N 0.000 claims description 4
- VNFPBHJOKIVQEB-UHFFFAOYSA-N clotrimazole Chemical compound ClC1=CC=CC=C1C(N1C=NC=C1)(C=1C=CC=CC=1)C1=CC=CC=C1 VNFPBHJOKIVQEB-UHFFFAOYSA-N 0.000 claims description 4
- 230000001225 therapeutic effect Effects 0.000 claims description 3
- 239000000825 pharmaceutical preparation Substances 0.000 claims description 2
- 239000002537 cosmetic Substances 0.000 claims 1
- 229940127557 pharmaceutical product Drugs 0.000 claims 1
- 241000206609 Porphyra Species 0.000 abstract description 6
- 235000006708 antioxidants Nutrition 0.000 description 25
- 150000003254 radicals Chemical class 0.000 description 24
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 21
- 101150018863 maa gene Proteins 0.000 description 19
- 150000001875 compounds Chemical class 0.000 description 15
- OENHQHLEOONYIE-UKMVMLAPSA-N all-trans beta-carotene Natural products CC=1CCCC(C)(C)C=1/C=C/C(/C)=C/C=C/C(/C)=C/C=C/C=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C OENHQHLEOONYIE-UKMVMLAPSA-N 0.000 description 13
- 239000011648 beta-carotene Substances 0.000 description 13
- 235000013734 beta-carotene Nutrition 0.000 description 13
- TUPZEYHYWIEDIH-WAIFQNFQSA-N beta-carotene Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CCCC1(C)C)C=CC=C(/C)C=CC2=CCCCC2(C)C TUPZEYHYWIEDIH-WAIFQNFQSA-N 0.000 description 13
- 229960002747 betacarotene Drugs 0.000 description 13
- WQGWDDDVZFFDIG-UHFFFAOYSA-N pyrogallol Chemical compound OC1=CC=CC(O)=C1O WQGWDDDVZFFDIG-UHFFFAOYSA-N 0.000 description 13
- OENHQHLEOONYIE-JLTXGRSLSA-N β-Carotene Chemical compound CC=1CCCC(C)(C)C=1\C=C\C(\C)=C\C=C\C(\C)=C\C=C\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C OENHQHLEOONYIE-JLTXGRSLSA-N 0.000 description 13
- 239000000126 substance Substances 0.000 description 12
- -1 superoxide anions Chemical class 0.000 description 12
- GVJHHUAWPYXKBD-IEOSBIPESA-N α-tocopherol Chemical compound OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-IEOSBIPESA-N 0.000 description 12
- OHDRQQURAXLVGJ-HLVWOLMTSA-N azane;(2e)-3-ethyl-2-[(e)-(3-ethyl-6-sulfo-1,3-benzothiazol-2-ylidene)hydrazinylidene]-1,3-benzothiazole-6-sulfonic acid Chemical compound [NH4+].[NH4+].S/1C2=CC(S([O-])(=O)=O)=CC=C2N(CC)C\1=N/N=C1/SC2=CC(S([O-])(=O)=O)=CC=C2N1CC OHDRQQURAXLVGJ-HLVWOLMTSA-N 0.000 description 11
- 230000000694 effects Effects 0.000 description 11
- 230000009102 absorption Effects 0.000 description 9
- 238000010521 absorption reaction Methods 0.000 description 9
- 238000006243 chemical reaction Methods 0.000 description 9
- 235000013305 food Nutrition 0.000 description 9
- 230000003647 oxidation Effects 0.000 description 9
- 238000007254 oxidation reaction Methods 0.000 description 9
- 241000195493 Cryptophyta Species 0.000 description 7
- 238000002835 absorbance Methods 0.000 description 7
- 229940079877 pyrogallol Drugs 0.000 description 7
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 6
- 229940087168 alpha tocopherol Drugs 0.000 description 6
- 230000003859 lipid peroxidation Effects 0.000 description 6
- 102000004169 proteins and genes Human genes 0.000 description 6
- 108090000623 proteins and genes Proteins 0.000 description 6
- 229960000984 tocofersolan Drugs 0.000 description 6
- 235000004835 α-tocopherol Nutrition 0.000 description 6
- 239000002076 α-tocopherol Substances 0.000 description 6
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 5
- MYMOFIZGZYHOMD-UHFFFAOYSA-N Dioxygen Chemical compound O=O MYMOFIZGZYHOMD-UHFFFAOYSA-N 0.000 description 5
- 102000004190 Enzymes Human genes 0.000 description 5
- 108090000790 Enzymes Proteins 0.000 description 5
- OYHQOLUKZRVURQ-HZJYTTRNSA-N Linoleic acid Chemical compound CCCCC\C=C/C\C=C/CCCCCCCC(O)=O OYHQOLUKZRVURQ-HZJYTTRNSA-N 0.000 description 5
- 102000003992 Peroxidases Human genes 0.000 description 5
- 230000004075 alteration Effects 0.000 description 5
- 230000006870 function Effects 0.000 description 5
- 235000020778 linoleic acid Nutrition 0.000 description 5
- OYHQOLUKZRVURQ-IXWMQOLASA-N linoleic acid Natural products CCCCC\C=C/C\C=C\CCCCCCCC(O)=O OYHQOLUKZRVURQ-IXWMQOLASA-N 0.000 description 5
- 238000000746 purification Methods 0.000 description 5
- GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 description 4
- 102000019197 Superoxide Dismutase Human genes 0.000 description 4
- 108010012715 Superoxide dismutase Proteins 0.000 description 4
- 239000007864 aqueous solution Substances 0.000 description 4
- 230000002255 enzymatic effect Effects 0.000 description 4
- RWSXRVCMGQZWBV-WDSKDSINSA-N glutathione Chemical compound OC(=O)[C@@H](N)CCC(=O)N[C@@H](CS)C(=O)NCC(O)=O RWSXRVCMGQZWBV-WDSKDSINSA-N 0.000 description 4
- 238000004128 high performance liquid chromatography Methods 0.000 description 4
- 108040007629 peroxidase activity proteins Proteins 0.000 description 4
- 239000013641 positive control Substances 0.000 description 4
- 230000005855 radiation Effects 0.000 description 4
- 239000012429 reaction media Substances 0.000 description 4
- 238000000926 separation method Methods 0.000 description 4
- WXEQFJUHQIGKNG-MZNRBSSJSA-N shinorine Chemical compound COC1=C(C[C@@](O)(CO)C\C1=N/[C@@H](CO)C(O)=O)NCC(O)=O WXEQFJUHQIGKNG-MZNRBSSJSA-N 0.000 description 4
- WXEQFJUHQIGKNG-UHFFFAOYSA-N shinorine Natural products COC1=C(CC(O)(CO)C/C/1=NC(CO)C(=O)O)NCC(=O)O WXEQFJUHQIGKNG-UHFFFAOYSA-N 0.000 description 4
- 238000012360 testing method Methods 0.000 description 4
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 4
- XZQILKYKJYHEHD-JTQLQIEISA-N 2-[[(5s)-5-hydroxy-5-(hydroxymethyl)-2-methoxy-3-oxocyclohexen-1-yl]amino]acetic acid Chemical compound COC1=C(NCC(O)=O)C[C@@](O)(CO)CC1=O XZQILKYKJYHEHD-JTQLQIEISA-N 0.000 description 3
- 235000014653 Carica parviflora Nutrition 0.000 description 3
- MHAJPDPJQMAIIY-UHFFFAOYSA-N Hydrogen peroxide Chemical compound OO MHAJPDPJQMAIIY-UHFFFAOYSA-N 0.000 description 3
- 241000206613 Pyropia yezoensis Species 0.000 description 3
- 239000008346 aqueous phase Substances 0.000 description 3
- 230000015572 biosynthetic process Effects 0.000 description 3
- 238000004061 bleaching Methods 0.000 description 3
- 230000015556 catabolic process Effects 0.000 description 3
- 210000004027 cell Anatomy 0.000 description 3
- 210000000170 cell membrane Anatomy 0.000 description 3
- 230000001413 cellular effect Effects 0.000 description 3
- 238000004587 chromatography analysis Methods 0.000 description 3
- 235000014113 dietary fatty acids Nutrition 0.000 description 3
- 238000002845 discoloration Methods 0.000 description 3
- 229930195729 fatty acid Natural products 0.000 description 3
- 239000000194 fatty acid Substances 0.000 description 3
- 150000004665 fatty acids Chemical class 0.000 description 3
- 150000004676 glycans Chemical class 0.000 description 3
- 125000004435 hydrogen atom Chemical class [H]* 0.000 description 3
- 238000000338 in vitro Methods 0.000 description 3
- 239000003112 inhibitor Substances 0.000 description 3
- 230000005764 inhibitory process Effects 0.000 description 3
- 229940126707 lipid peroxidation inhibitor Drugs 0.000 description 3
- 230000014759 maintenance of location Effects 0.000 description 3
- 230000004048 modification Effects 0.000 description 3
- 238000012986 modification Methods 0.000 description 3
- XZQILKYKJYHEHD-UHFFFAOYSA-N mycosporine glycine Natural products COC1=C(NCC(O)=O)CC(O)(CO)CC1=O XZQILKYKJYHEHD-UHFFFAOYSA-N 0.000 description 3
- 230000036542 oxidative stress Effects 0.000 description 3
- 229920001282 polysaccharide Polymers 0.000 description 3
- 239000005017 polysaccharide Substances 0.000 description 3
- 238000004321 preservation Methods 0.000 description 3
- 230000009919 sequestration Effects 0.000 description 3
- 241000894007 species Species 0.000 description 3
- 238000001228 spectrum Methods 0.000 description 3
- FPIPGXGPPPQFEQ-UHFFFAOYSA-N 13-cis retinol Natural products OCC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-UHFFFAOYSA-N 0.000 description 2
- 241000242757 Anthozoa Species 0.000 description 2
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 2
- 102000016938 Catalase Human genes 0.000 description 2
- 108010053835 Catalase Proteins 0.000 description 2
- 241000196324 Embryophyta Species 0.000 description 2
- 241000233866 Fungi Species 0.000 description 2
- 102000006587 Glutathione peroxidase Human genes 0.000 description 2
- 108700016172 Glutathione peroxidases Proteins 0.000 description 2
- 241000028378 Lichina pygmaea Species 0.000 description 2
- KYCBIRYKYQCBFO-KPKJPENVSA-N Palythine Chemical compound COC1=C(N)CC(O)(CO)C\C1=[NH+]/CC([O-])=O KYCBIRYKYQCBFO-KPKJPENVSA-N 0.000 description 2
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 2
- FPIPGXGPPPQFEQ-BOOMUCAASA-N Vitamin A Natural products OC/C=C(/C)\C=C\C=C(\C)/C=C/C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-BOOMUCAASA-N 0.000 description 2
- 238000000862 absorption spectrum Methods 0.000 description 2
- 239000002253 acid Substances 0.000 description 2
- FPIPGXGPPPQFEQ-OVSJKPMPSA-N all-trans-retinol Chemical compound OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-OVSJKPMPSA-N 0.000 description 2
- 235000010323 ascorbic acid Nutrition 0.000 description 2
- 239000011668 ascorbic acid Substances 0.000 description 2
- 229960005070 ascorbic acid Drugs 0.000 description 2
- 239000012620 biological material Substances 0.000 description 2
- 229910052799 carbon Inorganic materials 0.000 description 2
- HKZLNGQCWGVZIW-UHFFFAOYSA-N cyclohex-2-en-1-imine Chemical group N=C1CCCC=C1 HKZLNGQCWGVZIW-UHFFFAOYSA-N 0.000 description 2
- FWFSEYBSWVRWGL-UHFFFAOYSA-N cyclohex-2-enone Chemical compound O=C1CCCC=C1 FWFSEYBSWVRWGL-UHFFFAOYSA-N 0.000 description 2
- 230000006378 damage Effects 0.000 description 2
- 238000004042 decolorization Methods 0.000 description 2
- 230000007423 decrease Effects 0.000 description 2
- 238000006731 degradation reaction Methods 0.000 description 2
- 201000010099 disease Diseases 0.000 description 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 2
- 231100000673 dose–response relationship Toxicity 0.000 description 2
- 235000013399 edible fruits Nutrition 0.000 description 2
- 238000002474 experimental method Methods 0.000 description 2
- 238000000605 extraction Methods 0.000 description 2
- 235000012631 food intake Nutrition 0.000 description 2
- 229960003180 glutathione Drugs 0.000 description 2
- 230000009931 harmful effect Effects 0.000 description 2
- 229910052739 hydrogen Inorganic materials 0.000 description 2
- 239000001257 hydrogen Substances 0.000 description 2
- OUUQCZGPVNCOIJ-UHFFFAOYSA-N hydroperoxyl Chemical compound O[O] OUUQCZGPVNCOIJ-UHFFFAOYSA-N 0.000 description 2
- 230000000977 initiatory effect Effects 0.000 description 2
- 238000004255 ion exchange chromatography Methods 0.000 description 2
- 230000002427 irreversible effect Effects 0.000 description 2
- 238000004519 manufacturing process Methods 0.000 description 2
- 239000012528 membrane Substances 0.000 description 2
- 239000002207 metabolite Substances 0.000 description 2
- 239000000203 mixture Substances 0.000 description 2
- 235000016709 nutrition Nutrition 0.000 description 2
- 229910052760 oxygen Inorganic materials 0.000 description 2
- 239000001301 oxygen Substances 0.000 description 2
- AJGGWXHQTXRTPE-SNVBAGLBSA-N palythine Natural products COC1=C(C[C@@](O)(CO)CC1=N)NCC(=O)O AJGGWXHQTXRTPE-SNVBAGLBSA-N 0.000 description 2
- 239000012071 phase Substances 0.000 description 2
- 230000003711 photoprotective effect Effects 0.000 description 2
- 229920001467 poly(styrenesulfonates) Polymers 0.000 description 2
- 238000001556 precipitation Methods 0.000 description 2
- 239000002243 precursor Substances 0.000 description 2
- 239000011347 resin Substances 0.000 description 2
- 229920005989 resin Polymers 0.000 description 2
- 230000004044 response Effects 0.000 description 2
- 238000002390 rotary evaporation Methods 0.000 description 2
- 239000003352 sequestering agent Substances 0.000 description 2
- 238000002798 spectrophotometry method Methods 0.000 description 2
- 239000013589 supplement Substances 0.000 description 2
- XOAAWQZATWQOTB-UHFFFAOYSA-N taurine Chemical compound NCCS(O)(=O)=O XOAAWQZATWQOTB-UHFFFAOYSA-N 0.000 description 2
- 235000013311 vegetables Nutrition 0.000 description 2
- 235000019155 vitamin A Nutrition 0.000 description 2
- 239000011719 vitamin A Substances 0.000 description 2
- 229940045997 vitamin a Drugs 0.000 description 2
- OYHQOLUKZRVURQ-NTGFUMLPSA-N (9Z,12Z)-9,10,12,13-tetratritiooctadeca-9,12-dienoic acid Chemical compound C(CCCCCCC\C(=C(/C\C(=C(/CCCCC)\[3H])\[3H])\[3H])\[3H])(=O)O OYHQOLUKZRVURQ-NTGFUMLPSA-N 0.000 description 1
- HWSJJSITUUMTSO-UHFFFAOYSA-N 2-[[5-hydroxy-5-(hydroxymethyl)-3-(1-hydroxypropan-2-ylamino)-2-methoxycyclohex-2-en-1-ylidene]amino]acetic acid Chemical compound COC1=C(NC(C)CO)CC(O)(CO)CC1=NCC(O)=O HWSJJSITUUMTSO-UHFFFAOYSA-N 0.000 description 1
- MBPQVWGCNCNOQG-UHFFFAOYSA-N 2-aminocyclohex-2-en-1-one Chemical class NC1=CCCCC1=O MBPQVWGCNCNOQG-UHFFFAOYSA-N 0.000 description 1
- 125000003903 2-propenyl group Chemical group [H]C([*])([H])C([H])=C([H])[H] 0.000 description 1
- RVBUGGBMJDPOST-UHFFFAOYSA-N 2-thiobarbituric acid Chemical compound O=C1CC(=O)NC(=S)N1 RVBUGGBMJDPOST-UHFFFAOYSA-N 0.000 description 1
- 241000251468 Actinopterygii Species 0.000 description 1
- 241001661607 Bostrychia scorpioides Species 0.000 description 1
- 208000002177 Cataract Diseases 0.000 description 1
- 241000192703 Chlorogloeopsis Species 0.000 description 1
- 241000243321 Cnidaria Species 0.000 description 1
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 description 1
- 230000033616 DNA repair Effects 0.000 description 1
- 241001428241 Gelidium sesquipedale Species 0.000 description 1
- 108010024636 Glutathione Proteins 0.000 description 1
- 239000004471 Glycine Substances 0.000 description 1
- 241001428248 Gymnogongrus Species 0.000 description 1
- 241001147489 Mastocarpus stellatus Species 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- VVTDHOIRNPCGTH-NSHDSACASA-N Mycosporine Chemical compound COC1=C(NC(CO)CO)C[C@@](O)(CO)CC1=O VVTDHOIRNPCGTH-NSHDSACASA-N 0.000 description 1
- QPCDCPDFJACHGM-UHFFFAOYSA-N N,N-bis{2-[bis(carboxymethyl)amino]ethyl}glycine Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(=O)O)CCN(CC(O)=O)CC(O)=O QPCDCPDFJACHGM-UHFFFAOYSA-N 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- 229910019142 PO4 Inorganic materials 0.000 description 1
- 241000206754 Palmaria palmata Species 0.000 description 1
- 108700020962 Peroxidase Proteins 0.000 description 1
- 206010051246 Photodermatosis Diseases 0.000 description 1
- 241000434565 Platygyra ryukyuensis Species 0.000 description 1
- 241000321455 Plectropomus leopardus Species 0.000 description 1
- 229920001213 Polysorbate 20 Polymers 0.000 description 1
- 241000277331 Salmonidae Species 0.000 description 1
- 241000490569 Stylophora pistillata Species 0.000 description 1
- OUUQCZGPVNCOIJ-UHFFFAOYSA-M Superoxide Chemical compound [O-][O] OUUQCZGPVNCOIJ-UHFFFAOYSA-M 0.000 description 1
- 229930003268 Vitamin C Natural products 0.000 description 1
- 229930003427 Vitamin E Natural products 0.000 description 1
- 239000000654 additive Substances 0.000 description 1
- 230000000996 additive effect Effects 0.000 description 1
- 150000001299 aldehydes Chemical class 0.000 description 1
- 125000001931 aliphatic group Chemical group 0.000 description 1
- 239000012670 alkaline solution Substances 0.000 description 1
- 150000001414 amino alcohols Chemical class 0.000 description 1
- 230000006851 antioxidant defense Effects 0.000 description 1
- 239000006286 aqueous extract Substances 0.000 description 1
- 238000003556 assay Methods 0.000 description 1
- 238000006701 autoxidation reaction Methods 0.000 description 1
- 150000001579 beta-carotenes Chemical class 0.000 description 1
- 239000003181 biological factor Substances 0.000 description 1
- 239000000872 buffer Substances 0.000 description 1
- 238000004364 calculation method Methods 0.000 description 1
- 125000004432 carbon atom Chemical group C* 0.000 description 1
- 150000001723 carbon free-radicals Chemical class 0.000 description 1
- 230000005779 cell damage Effects 0.000 description 1
- 208000037887 cell injury Diseases 0.000 description 1
- 239000013626 chemical specie Substances 0.000 description 1
- 230000001934 delay Effects 0.000 description 1
- 230000001419 dependent effect Effects 0.000 description 1
- 230000001066 destructive effect Effects 0.000 description 1
- 230000006866 deterioration Effects 0.000 description 1
- 230000002542 deteriorative effect Effects 0.000 description 1
- 229910001882 dioxygen Inorganic materials 0.000 description 1
- 239000012154 double-distilled water Substances 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 239000003480 eluent Substances 0.000 description 1
- 238000010828 elution Methods 0.000 description 1
- 230000037149 energy metabolism Effects 0.000 description 1
- 238000007824 enzymatic assay Methods 0.000 description 1
- 230000005284 excitation Effects 0.000 description 1
- 238000005562 fading Methods 0.000 description 1
- 239000003925 fat Substances 0.000 description 1
- 235000019197 fats Nutrition 0.000 description 1
- 229930003935 flavonoid Natural products 0.000 description 1
- 235000017173 flavonoids Nutrition 0.000 description 1
- 150000002215 flavonoids Chemical class 0.000 description 1
- 239000000796 flavoring agent Substances 0.000 description 1
- 235000019634 flavors Nutrition 0.000 description 1
- 238000009472 formulation Methods 0.000 description 1
- 239000003574 free electron Substances 0.000 description 1
- 125000000524 functional group Chemical group 0.000 description 1
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 description 1
- 230000012010 growth Effects 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 150000002432 hydroperoxides Chemical class 0.000 description 1
- TUJKJAMUKRIRHC-UHFFFAOYSA-N hydroxyl Chemical compound [OH] TUJKJAMUKRIRHC-UHFFFAOYSA-N 0.000 description 1
- 238000000099 in vitro assay Methods 0.000 description 1
- 230000002779 inactivation Effects 0.000 description 1
- 238000011534 incubation Methods 0.000 description 1
- 230000002757 inflammatory effect Effects 0.000 description 1
- 238000005342 ion exchange Methods 0.000 description 1
- 230000037427 ion transport Effects 0.000 description 1
- 150000008040 ionic compounds Chemical class 0.000 description 1
- SUBFIBLJQMMKBK-UHFFFAOYSA-K iron(3+);trithiocyanate Chemical compound [Fe+3].[S-]C#N.[S-]C#N.[S-]C#N SUBFIBLJQMMKBK-UHFFFAOYSA-K 0.000 description 1
- 210000002510 keratinocyte Anatomy 0.000 description 1
- 238000003367 kinetic assay Methods 0.000 description 1
- 238000012417 linear regression Methods 0.000 description 1
- 150000002632 lipids Chemical class 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 239000000401 methanolic extract Substances 0.000 description 1
- 125000000325 methylidene group Chemical group [H]C([H])=* 0.000 description 1
- 244000005700 microbiome Species 0.000 description 1
- 239000011859 microparticle Substances 0.000 description 1
- 230000035772 mutation Effects 0.000 description 1
- 239000013642 negative control Substances 0.000 description 1
- 235000008935 nutritious Nutrition 0.000 description 1
- YTJSFYQNRXLOIC-UHFFFAOYSA-N octadecylsilane Chemical compound CCCCCCCCCCCCCCCCCC[SiH3] YTJSFYQNRXLOIC-UHFFFAOYSA-N 0.000 description 1
- 235000019645 odor Nutrition 0.000 description 1
- 230000000065 osmolyte Effects 0.000 description 1
- 230000001590 oxidative effect Effects 0.000 description 1
- NKJVQFFOGWSVTJ-AMIZOPFISA-N palythinol Natural products COC1=C(C[C@](O)(CO)CC1=N[C@H](C)CO)NCC(=O)O NKJVQFFOGWSVTJ-AMIZOPFISA-N 0.000 description 1
- 230000036961 partial effect Effects 0.000 description 1
- 230000007170 pathology Effects 0.000 description 1
- 229960003330 pentetic acid Drugs 0.000 description 1
- 229940097156 peroxyl Drugs 0.000 description 1
- NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 description 1
- 239000010452 phosphate Substances 0.000 description 1
- 239000008363 phosphate buffer Substances 0.000 description 1
- WTJKGGKOPKCXLL-RRHRGVEJSA-N phosphatidylcholine Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCCCCCCC=CCCCCCCCC WTJKGGKOPKCXLL-RRHRGVEJSA-N 0.000 description 1
- 150000003904 phospholipids Chemical class 0.000 description 1
- 230000008845 photoaging Effects 0.000 description 1
- 230000000243 photosynthetic effect Effects 0.000 description 1
- 230000035479 physiological effects, processes and functions Effects 0.000 description 1
- 230000035790 physiological processes and functions Effects 0.000 description 1
- 239000000049 pigment Substances 0.000 description 1
- 239000000256 polyoxyethylene sorbitan monolaurate Substances 0.000 description 1
- 235000010486 polyoxyethylene sorbitan monolaurate Nutrition 0.000 description 1
- 235000013824 polyphenols Nutrition 0.000 description 1
- 230000000644 propagated effect Effects 0.000 description 1
- 238000011002 quantification Methods 0.000 description 1
- 239000002516 radical scavenger Substances 0.000 description 1
- 238000006479 redox reaction Methods 0.000 description 1
- 230000027272 reproductive process Effects 0.000 description 1
- 230000008054 signal transmission Effects 0.000 description 1
- 239000000377 silicon dioxide Substances 0.000 description 1
- 150000003384 small molecules Chemical class 0.000 description 1
- 239000000243 solution Substances 0.000 description 1
- 230000003595 spectral effect Effects 0.000 description 1
- 230000006641 stabilisation Effects 0.000 description 1
- 238000011105 stabilization Methods 0.000 description 1
- 230000035882 stress Effects 0.000 description 1
- 239000000758 substrate Substances 0.000 description 1
- 230000036561 sun exposure Effects 0.000 description 1
- 230000004083 survival effect Effects 0.000 description 1
- 229960003080 taurine Drugs 0.000 description 1
- 230000008646 thermal stress Effects 0.000 description 1
- 230000008719 thickening Effects 0.000 description 1
- 230000000699 topical effect Effects 0.000 description 1
- 238000013518 transcription Methods 0.000 description 1
- 230000035897 transcription Effects 0.000 description 1
- 229910001428 transition metal ion Inorganic materials 0.000 description 1
- 238000013519 translation Methods 0.000 description 1
- 230000014616 translation Effects 0.000 description 1
- OMPMQQQHTAPTHR-UHFFFAOYSA-N usujirene Natural products COC1=C(CC(O)(CO)C/C/1=NC=C/C)NCC(=O)O OMPMQQQHTAPTHR-UHFFFAOYSA-N 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- 235000019154 vitamin C Nutrition 0.000 description 1
- 239000011718 vitamin C Substances 0.000 description 1
- 235000019165 vitamin E Nutrition 0.000 description 1
- 239000011709 vitamin E Substances 0.000 description 1
- 229940046009 vitamin E Drugs 0.000 description 1
- 239000003643 water by type Substances 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/02—Algae
- A61K36/04—Rhodophycota or rhodophyta (red algae), e.g. Porphyra
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/17—Amino acids, peptides or proteins
- A23L33/175—Amino acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/40—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
- A61K8/44—Aminocarboxylic acids or derivatives thereof, e.g. aminocarboxylic acids containing sulfur; Salts; Esters or N-acylated derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/40—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
- A61K8/44—Aminocarboxylic acids or derivatives thereof, e.g. aminocarboxylic acids containing sulfur; Salts; Esters or N-acylated derivatives thereof
- A61K8/442—Aminocarboxylic acids or derivatives thereof, e.g. aminocarboxylic acids containing sulfur; Salts; Esters or N-acylated derivatives thereof substituted by amido group(s)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/18—Antioxidants, e.g. antiradicals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/12—Ophthalmic agents for cataracts
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P39/00—General protective or antinoxious agents
- A61P39/06—Free radical scavengers or antioxidants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
- A61K2800/52—Stabilizers
- A61K2800/522—Antioxidants; Radical scavengers
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Biotechnology (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Epidemiology (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Mycology (AREA)
- Botany (AREA)
- Microbiology (AREA)
- Medical Informatics (AREA)
- Alternative & Traditional Medicine (AREA)
- Birds (AREA)
- Dermatology (AREA)
- Biochemistry (AREA)
- Ophthalmology & Optometry (AREA)
- Food Science & Technology (AREA)
- Toxicology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Nutrition Science (AREA)
- Psychology (AREA)
- Polymers & Plastics (AREA)
- Hospice & Palliative Care (AREA)
- Psychiatry (AREA)
- Food Preservation Except Freezing, Refrigeration, And Drying (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
Uso de aminoácido tipo micosporina (porfira 334) en productos para prevención de procesos cancerígenos. La presente invención se encuadra en el sector biotecnológico y describe el potencial uso de un aminoácido tipo micosporina (MAA) concretamente de porfira 334 aislado del alga roja Porphyra leucostica, además de su posible aplicación en preparados farmacéuticos, nutraceúticos, o alimentos funcionales, entre otros, para prevención procesos cancerígenos.Use of mycosporine-type amino acid (porfira 334) in products for the prevention of carcinogenic processes. The present invention is part of the biotechnology sector and describes the potential use of a mycosporin-like amino acid (MAA) specifically porfira 334 isolated from the red seaweed Porphyra leucostica , in addition to its possible application in pharmaceutical, nutraceutical, or functional food preparations, among others , for prevention of carcinogenic processes.
Description
Uso de aminoácido tipo micosporina (porfira 334) en productos para prevención de procesos cancerígenos.Use of mycosporin-like amino acid (porfira 334) in products for the prevention of carcinogenic processes.
La presente invención se encuadra en el sector biotecnológico y describe el potencial uso de un aminoácido tipo micosporina (MAA), concretamente de porfira 334 aislado del alga roja Porphyra leucostica, además de su posible aplicación en preparados farmacéuticos, nutracéuticos, o alimentos funcionales, entre otros, para prevención procesos cancerígenos.The present invention is part of the biotechnology sector and describes the potential use of a mycosporin-like amino acid (MAA), specifically porphyry 334 isolated from the red algae Porphyra leucostica , in addition to its possible application in pharmaceutical preparations, nutraceuticals, or functional foods, among others, for the prevention of carcinogenic processes.
La radiación ultravioleta es uno de factores biológicos que limitan la supervivencia, fisiología y crecimiento de muchos organismos. Algunos de los múltiples efectos dañinos de la radiación UV incluye la alteración de moléculas de ADN y proteínas, inactivación de enzimas y a la formación de radicales libres, los cuales atacan a membranas celulares y otras moléculas diana alterando su funcionalidad. Todos los organismos aerobios disponen de una gran variedad de sistemas de defensa antioxidante tanto enzimáticos como no enzimáticos que se coordinan cooperativamente y protegen al organismo de los riesgos que conlleva el estrés oxidativo. Entre ellos destacan las actividades enzimáticas de la superóxido dismutasa (SOD), glutatión peroxidasa (GPX) y catalasa (CAT); además del ácido ascórbico (vitamina C), \alpha-tocoferol (vitamina E), glutatión (GSH), \beta-caroteno, vitamina A, flavonoides y ácidos fenólicos entre otros.Ultraviolet radiation is one of factors biological factors that limit survival, physiology and growth of many organisms. Some of the multiple harmful effects of UV radiation includes the alteration of DNA molecules and proteins, enzyme inactivation and radical formation free, which attack cell membranes and other molecules target altering its functionality. All aerobic organisms they have a wide variety of antioxidant defense systems both enzymatic and non-enzymatic that coordinate cooperatively and protect the body from the risks involved oxidative stress Among them, the activities stand out Enzymatic superoxide dismutase (SOD), glutathione peroxidase (GPX) and catalase (CAT); in addition to ascorbic acid (vitamin C), α-tocopherol (vitamin E), glutathione (GSH), β-carotene, vitamin A, flavonoids and acids Phenolic among others.
Se entiende por radical libre a cualquier especie química que contiene uno o más electrones desapareados en sus orbitales externos de manera que un compuesto puede convertirse en radical libre captando o perdiendo un electrón. Aunque existen radicales libres de muy distinta naturaleza, son las especies que derivan de la molécula de oxígeno (ROS) las más abundantes en los organismos aerobios destacando productos de la ruptura o la excitación del O_{2} como el oxígeno singlete ^{1}O_{2} y especies de oxígeno que están parcialmente reducidas como el radical hidroxilo (OH\bullet), aniones superóxido (O_{2}^{-}) y peróxido de hidrógeno (H_{2}O_{2}). Estas moléculas inestables recorren el organismo tomando electrones con lo que recuperan su estabilidad electroquímica, esto las hace muy peligrosas porque para conseguirlo atacan moléculas estables. Una vez que el radical libre ha conseguido tomar el electrón que necesita para emparejar su electrón libre, la otra molécula se convierte a su vez en un radical libre, iniciándose así un ciclo destructivo para nuestras células.Free radical is understood as any chemical species that contains one or more missing electrons in its external orbitals so that a compound can become in free radical capturing or losing an electron. Although they exist free radicals of very different nature, are the species that derive from the oxygen molecule (ROS) the most abundant in aerobic organisms highlighting breakdown products or the excitation of O2 as singlet oxygen1O2 and oxygen species that are partially reduced as the hydroxyl radical (OH •), superoxide anions (O 2 -) and hydrogen peroxide (H2O2). These molecules unstable travel the body taking electrons with what they recover their electrochemical stability, this makes them very dangerous because to achieve this attack stable molecules. A once the free radical has managed to take the electron that you need to pair your free electron, the other molecule will turn in turn into a free radical, thus initiating a cycle destructive to our cells.
Los radicales libres dan lugar a alteraciones importantes en moléculas como ADN, lípidos y proteínas, alterando gravemente el ciclo y la funcionalidad celular. El ADN puede sufrir pérdida de bases así como la ruptura de una o de ambas hebras del material genético, alteraciones que pueden traducirse en mutaciones irreversibles. Muchas proteínas son capaces de absorber una gran cantidad de oxidaciones sin que aparentemente se vea afectada su función. Sin embargo, es indudable que las consecuencias de las alteraciones en algunas funciones, por ejemplo, la recepción y transmisión de señales, el transporte de iones, la duplicación y reparación del ADN, las respuestas a condiciones de tensión y el metabolismo energético, la transcripción y traducción pueden ser críticas para la célula. Los daños producidos por el OH\bullet y el ^{1}O_{2} son irreversibles y en términos generales marcan las proteínas para su degradación. Las membranas celulares también pueden resultar seriamente dañadas en situación de estrés oxidativo ya que fosfolípidos que tienen ácidos grasos con varios dobles enlaces son muy susceptibles a la oxidación por pérdida de un hidrógeno (alílico).Una vez generado el radical carbono en un ácido graso, éste reacciona con el oxígeno molecular formando un radical peroxilo. El radical peroxilo puede tomar un hidrógeno alílico a otro metileno con lo cual se propaga la reacción. Los hidroperóxidos, que son compuestos estables, si entran en contacto con iones metálicos de transición producirán más radicales libres que iniciarán y propagarán otras reacciones en cadena. Así, las membranas resultan seriamente dañadas y por tanto su funcionalidad se ve alterada.Free radicals give rise to alterations important in molecules such as DNA, lipids and proteins, altering seriously the cycle and cellular functionality. DNA can suffer loss of bases as well as the breakage of one or both strands of the genetic material, alterations that can result in mutations irreversible Many proteins are able to absorb a large amount of oxidation without seemingly affected its function. However, there is no doubt that the consequences of alterations in some functions, for example, reception and signal transmission, ion transport, duplication and DNA repair, responses to stress conditions and the energy metabolism, transcription and translation can be Critics for the cell. Damage caused by OH \ and the 1 O 2 are irreversible and generally mark Proteins for degradation. Cell membranes too may be seriously damaged in oxidative stress since phospholipids that have fatty acids with several doubles bonds are very susceptible to oxidation by loss of a hydrogen (allyl) Once the carbon radical is generated in a fatty acid, it reacts with molecular oxygen forming a peroxyl radical. The peroxyl radical can take a hydrogen allyl to another methylene whereby the reaction is propagated. The hydroperoxides, which are stable compounds, if they come into contact with transition metal ions will produce more free radicals that will initiate and spread other chain reactions. So, the membranes are seriously damaged and therefore their functionality It is altered.
Los radicales libres se asocian con un amplio rango de patologías y enfermedades como el Alzheimer o el Parkinson y afecciones relacionadas con la exposición solar como la aparición de cataratas, fotoenvejecimiento, episodios inflamatorios y neoplasias. También son los responsables de la oxidación de las grasas de los alimentos, que es la forma de deterioro más importante después de las alteraciones producidas por microorganismos. Con la oxidación, aparecen olores y sabores a rancio, se altera el color y la textura, y desciende el valor nutritivo al perderse algunas vitaminas y ácidos grasos poliinsaturados. Además, los productos formados en la oxidación pueden llegar a ser nocivos para la salud.Free radicals are associated with a broad range of pathologies and diseases such as Alzheimer's or Parkinson's and conditions related to sun exposure such as appearance of cataracts, photoaging, inflammatory episodes and neoplasms. They are also responsible for the oxidation of food fats, which is the most deteriorating form important after the alterations produced by microorganisms With oxidation, odors and flavors appear stale, the color and texture are altered, and the value drops nutritious when missing some vitamins and fatty acids polyunsaturated In addition, products formed in oxidation They can become harmful to health.
Los aminoácidos tipo micosporina están constituidos por un anillo de ciclohexenona o de ciclohexenimina, conjugado con un sustituyente nitrogenado de un aminoácido o su aminoalcohol que actúa como cromóforo permitiendo la absorción de determinada radiación de onda corta. Los metabolitos que se aíslan en hongos presentan un rango de absorción entre 310 y 320 nm y poseen anillos de ciclohexenona exclusivamente, conociéndoseles por el nombre de micosporinas en referencia a su origen. Por el contrario, los metabolitos que se aíslan de organismos marinos y algas contienen anillos de ciclohexenimina, con absorciones máximas entre 310 y 360 nm y se les conoce con el nombre de aminoácidos tipo micosporina ó MAAs. Aún así, la mycosporine-glycine y la mycosporine taurine son aminociclohexenonas aisladas de organismos marinos. En la actualidad hay descritas 13 micosporinas distintas en hongos y 23 MAAs en organismos marinos. Son moléculas pequeñas, con pesos moleculares que rondan los 330 Da y presentan una alta fotoestabilidad. Se comportan como moléculas anfóteras, similares a los aminoácidos, de manera que presentan cargas positivas y negativas en la misma molécula. Muestran características físico-químicas propias de compuestos iónicos por ejemplo alto punto de efusión y alta solubilidad en agua.Mycosporin-type amino acids consist of a cyclohexenone or cyclohexenimine ring, conjugated with a nitrogenous substituent of an amino acid or its amino alcohol that acts as a chromophore allowing the absorption of certain shortwave radiation. The metabolites that are isolated in fungi have an absorption range between 310 and 320 nm and have cyclohexenone rings exclusively, being known by the name of mycosporins in reference to their origin. On the contrary, the metabolites that are isolated from marine organisms and algae contain cyclohexenimine rings, with maximum absorptions between 310 and 360 nm and are known as mycosporine-type amino acids or MAAs . Still, mycosporine-glycine and mycosporine taurine are aminocyclohexenones isolated from marine organisms. There are currently 13 different mycosporins described in fungi and 23 MAAs in marine organisms. They are small molecules, with molecular weights around 330 Da and have high photostability. They behave like amphoteric molecules, similar to amino acids, so that they have positive and negative charges on the same molecule. They show physicochemical characteristics of ionic compounds, for example, high effusion point and high water solubility.
Son muchas las funciones que se les ha atribuido a estas moléculas en el organismo: desde osmolito orgánico en comunidades cianobacterianas Chlorogloeopsis, pigmentos accesorios fotosintéticos o precursores de estos, a moléculas determinantes en procesos reproductivos de algunas especies de peces, sin embargo es el papel fotoprotector frente a la radiación UV el más aceptado y documentado ya que al parecer actúan protegiendo parcialmente a los componentes celulares y procesos fisiológicos. Un número de trabajos han evaluado este tipo de moléculas por sus actividad como fotoprotectores de uso tópico vehiculizando extractos naturales con un alto porcentaje de MAAs y viendo su FPS y su potencial fotoprotector en células vegetales, queratinocitos humanos, etc. (Patente US 6787147; Patente WO 02/39974; Patente WO 03/020236). También se han publicado trabajos que hacen referencia a las propiedades antioxidativas de extractos obtenidos de algas y corales.There are many functions that have been attributed to these molecules in the organism: from organic osmolyte in Chlorogloeopsis cyanobacterial communities, photosynthetic accessory pigments or precursors of these, to determining molecules in reproductive processes of some species of fish, however it is the photoprotective role against UV radiation the most accepted and documented since apparently they act partially protecting cellular components and physiological processes. A number of studies have evaluated these types of molecules for their activity as topical photoprotectors, vehiculating natural extracts with a high percentage of MAAs and seeing their SPF and their photoprotective potential in plant cells, human keratinocytes, etc. (US Patent 6787147; WO 02/39974; WO 03/020236). Works have also been published that refer to the antioxidant properties of extracts obtained from algae and corals.
Dunlap y Yamamoto en 1995 (Comp. Biochem. Physiol. 112: 105-114) apuntaron a una posible actividad antioxidante de mycosporine-glycine mediante ensayos in vitro de peroxidación lipídica (método de la fosfatidilcolina) a partir de extractos de organismos marinos que contenían MAAs, mientras que otras iminoMAAs como porphyra 334, shinorine, palythine, asterine 330 y palythinol se mostraban oxidativamente robustas y no participaban en reacciones de oxidación-reducción. No obstante, como se ha indicado, dichos ensayos fueron realizados con extractos algales que contenían además de MAAs un alto porcentaje de otros componentes celulares como polisacáridos, enzimas, etc., por lo que no es posible afirmar firmemente la actividad antioxidante de mycosporine-glycine (o M-gly) en base a dicho trabajo.Dunlap and Yamamoto in 1995 (Comp. Biochem. Physiol. 112: 105-114) pointed to a possible antioxidant activity of mycosporine-glycine by in vitro assays of lipid peroxidation (phosphatidylcholine method) from extracts of marine organisms containing MAAs, while other iminoMAAs such as porphyra 334, shinorine, palythine, asterine 330 and palythinol were oxidatively robust and did not participate in oxidation-reduction reactions. However, as indicated, these tests were carried out with algal extracts that, in addition to MAAs, contained a high percentage of other cellular components such as polysaccharides, enzymes, etc., so it is not possible to firmly affirm the antioxidant activity of mycosporine-glycine (or M-gly) based on that work.
Nakayama y colaboradores en 1999 (J. Am. Oil
Chem. Soc., 76: 649-653) aislaron un nuevo
aminoácido tipo micosporina del alga roja Porphyra yezoensis
llamado usujilene, ya identificado en Palmaria palmata pero
no en ninguna especie de Porphyra. Sus resultados indicaban
que tal MAA mostraba actividad antioxidante frente a la autoxidación
del ácido linoleico (Métodos del ácido tiobarbitúrico y tiocianato
férrico), donando determinados hidrógenos a radicales lipídicos LOO
y dando lugar a moléculas de MAAs estabilizadas por resonancia al
igual que el
\alpha-tocoferol.Nakayama et al. In 1999 (J. Am. Oil Chem. Soc., 76: 649-653) isolated a new mycosporin-like amino acid from the red algae Porphyra yezoensis called usujilene, already identified in Palmaria palmata but not in any species of Porphyra . Their results indicated that such MAA showed antioxidant activity against linoleic acid autoxidation (Thiobarbituric acid and ferric thiocyanate methods), donating certain hydrogens to LOO lipid radicals and giving rise to resonance stabilized MAA molecules as well as
α-tocopherol.
Suh y colaboradores en 2003 (Photochem. Photobiol. 78: 109-113) sugieren también la función antioxidante de la M-gly, pero probablemente actuando junto con otros MAAs activos. La M-gly, entre otros, podría jugar un importante papel participando en la eliminación de O_{2}^{-} generado por sistemas fotosintetizadores endógenos.Suh et al. In 2003 (Photochem. Photobiol 78: 109-113) also suggest the function M-gly antioxidant, but probably acting together with other active MAAs. The M-gly, among others, could play an important role participating in the O_ {2} ^ {}} system-generated removal endogenous photosynthesizers.
Yakovleva y colaboradores en 2004 (Comp. Biochem. Physiol., 139: 721-739 examinaron la importancia de la M-gly como antioxidante funcional frente a estrés térmico en dos corales, Platygyra ryukyuensis y Stylophora pistillata, en base a la correlación entre el grado de susceptibilidad y la concentración endógena de M-gly.Yakovleva et al. In 2004 (Comp. Biochem. Physiol., 139: 721-739 examined the importance of M-gly as a functional antioxidant against thermal stress in two corals, Platygyra ryukyuensis and Stylophora pistillata , based on the correlation between degree of susceptibility and endogenous concentration of M-gly.
También la patente US2004228875 hace referencia a las propiedades antioxidativas de extractos obtenidos a partir de algas del género Porphyra, aunque sin concluir sobre el posible papel jugado por MAAs.Also the patent US2004228875 refers to the antioxidant properties of extracts obtained from algae of the genus Porphyra , although without concluding on the possible role played by MAAs.
Publicaciones más recientes analizan las propiedades antioxidativas de extractos obtenidos a partir de algas pero sin concretar la participación de MAAs (Yuan y colaboradores, 2005, Food Chem. Toxicol., 43: 1073-1081; Kuda y colaboradores, 2005, J. Food Compos. Anal., 18: 625-633).More recent publications analyze the antioxidant properties of extracts obtained from algae but without specifying the participation of MAAs (Yuan et al., 2005, Food Chem. Toxicol., 43: 1073-1081; Kuda and collaborators, 2005, J. Food Compos. Anal., 18: 625-633).
Se puede concluir, por tanto, que el papel antioxidante de los iminoMAAs como tales, es decir, purificados o aislados en un alto grado de pureza, no se conoce bien, como tampoco su comportamiento a nivel de secuestro de radicales libres hidrosolubles.It can be concluded, therefore, that the role antioxidant of iminoMAAs as such, that is, purified or isolated in a high degree of purity, it is not well known, nor is it its behavior at the level of free radical sequestration water soluble.
Un antioxidante se define como una sustancia que en bajas concentraciones comparado con un substrato oxidable, retrasa o previene su oxidación. La presente invención describe la potencialidad del MAA porphyra 334 aislado de Porphyra leucosticta como secuestrador de radicales e inhibidor de la peroxidación lipídica. En los ensayos realizados, el nuevo antioxidante es comparado con otro antioxidante ya conocido, el \alpha-tocoferol. El compuesto descrito podría utilizarse en aplicaciones terapeúticas, y en aplicaciones no médicas para la estabilización de compuestos susceptibles del deterioro oxidativo, en la preservación de alimentos o productos relacionados, y en complementos nutricionales, nutracéuticos, alimentos funcionales o de parafarmacia por sus propiedades antioxidantes para prevenir el estrés oxidativo.An antioxidant is defined as a substance that in low concentrations compared to an oxidizable substrate, delays or prevents its oxidation. The present invention describes the potentiality of the porphyra 334 MAA isolated from Porphyra leucosticta as a radical scavenger and lipid peroxidation inhibitor. In the tests performed, the new antioxidant is compared with another known antioxidant, α-tocopherol. The described compound could be used in therapeutic applications, and in non-medical applications for the stabilization of compounds susceptible to oxidative deterioration, in the preservation of food or related products, and in nutritional, nutraceutical, functional foods or parapharmacy supplements for their antioxidant properties for prevent oxidative stress.
Los MAAs se encuentran de manera natural en los
organismos aislados en orden de mg/g PS, destacando porphyra 334 que
se encuentra en el alga Porphyra leucosticta en orden de 3 -
6 mg/gPS. Como sabemos las algas marinas se han utilizado como
alimento humano desde la antigüedad, especialmente en los países
orientales y cuya cultura se encuentra en expansión en todo el
mundo. Porphyra (cuyo nombre vulgar en Japón es nori) es una
de las algas marinas más importantes utilizadas como alimento
humano. En los últimos años Porphyra ha figurado en las
estadísticas japonesas sobre pesca como la tercera captura en orden
de importancia y tiene un contenido elevado de valiosas proteínas
comestibles de manera que este estudio podría dar un valor añadido
a determinados tipo de alimentos
naturales.MAAs are found naturally in isolated organisms in the order of mg / g PS, highlighting porphyra 334 found in the Porphyra leucosticta algae in the order of 3-6 mg / gPS. As we know, seaweed has been used as human food since ancient times, especially in eastern countries and whose culture is expanding worldwide. Porphyra (whose vulgar name in Japan is nori) is one of the most important seaweed used as human food. In recent years Porphyra has been listed in Japanese fisheries statistics as the third catch in order of importance and has a high content of valuable edible proteins so that this study could give added value to certain types of food
natural
\newpage\ newpage
La presente invención presenta un compuesto aislado de Porphyra leucosticta con la siguiente estructura y de utilidad como antioxidante y secuestrador de radicales libres.The present invention presents an isolated compound of Porphyra leucosticta with the following structure and useful as an antioxidant and free radical sequestrant.
Se han purificado compuestos del tipo aminoácidos tipo micosporina en fase acuosa partiendo de Porphyra leucosticta. Los compuestos se han detectado y caracterizado por HPLC. Se empleó un detector UV-visible (detector de fotodiodos 996), que medía la absorbancia para cada muestra entre los 290 y 400 nm. Una vez extraído el cromatograma a 330 nm, se identificaron los picos por co-cromatografía según sus espectros y tiempos de retención, comparándose con estándares de MAAs.Compounds of the mycosporin type amino acid type have been purified in the aqueous phase starting from Porphyra leucosticta . The compounds have been detected and characterized by HPLC. A UV-visible detector (photodiode detector 996) was used, which measured the absorbance for each sample between 290 and 400 nm. Once the chromatogram was extracted at 330 nm, the peaks were identified by co-chromatography according to their spectra and retention times, compared to MAAs standards.
La extracción a escala preparativa se realizó disolviendo 60-80 g (PF) de material biológico en 1 litro de metanol al 20% v/v e incubándose en un baño termostático a 45°C durante 2 horas. Posteriormente se centrifuga el extracto a 14000 rpm durante 15 min y rotavaporación a 45°C para eliminar parte del metanol de la muestra.Preparatory scale extraction was performed dissolving 60-80 g (PF) of biological material in 1 liter of 20% v / v methanol and incubating in a thermostatic bath to 45 ° C for 2 hours. Subsequently, the extract is centrifuged at 14000 rpm for 15 min and rotary evaporation at 45 ° C to eliminate part of the methanol in the sample.
La purificación se realizó en tres pasos consecutivos en los que se combinan técnicas cromatográficas de absorción mediante la aplicación de carbono activo, precipitación de polisacáridos al añadir a la muestra metanol 100% y separación final mediante cromatografía de intercambio iónico. Finalmente se obtuvieron soluciones acuosas de MAA en alto grado de pureza en concentraciones del orden de mM.The purification was done in three steps Consecutive in which chromatographic techniques of absorption by the application of active carbon, precipitation of polysaccharides by adding 100% methanol to the sample and separation final by ion exchange chromatography. Finally I know they obtained aqueous solutions of MAA in high degree of purity in concentrations of the order of mM.
Para medir la actividad como secuestrador de radicales hidrosolubles se ha utilizado el método de la ABTS peroxidasa, el cual permite determinar la actividad antioxidante total (TAA) de una muestra entendida como un parámetro que permite cuantificar la capacidad de una muestra, natural o procesada, de secuestrar radicales libres presentes en una solución acuosa.To measure activity as a hijacker of water-soluble radicals the ABTS method has been used peroxidase, which allows to determine the antioxidant activity total (TAA) of a sample understood as a parameter that allows quantify the capacity of a sample, natural or processed, of sequester free radicals present in an aqueous solution.
Porphyra 334 aislado de Porphyra leucosticta no presenta actividad antioxidante signifcativa a ningún pH ensayado como inhibidor de la producción de radicales libres hidrosolubles (ABTS^{+}).Porphyra 334 isolated from Porphyra leucosticta has no significant antioxidant activity at any pH tested as an inhibitor of water-soluble free radical production (ABTS +).
Porphyra 334 aislado de Porphyra leucosticta se estudió como inhibidor de la peroxidación lipídica in vitro mediante la técnica de decoloración del \beta-caroteno. El método de decoloración del \beta-caroteno es ampliamente utilizado para la determinación de la capacidad antioxidante de diversas sustancias en medio lipofilico, la mayoría de ellas extraídas de frutas, vegetales y demás productos destinados a consumo alimentario para poder determinar su mayor o menor grado de autoconservación en estado natural. En este ensayo, como control positivo se utilizó el \alpha-tocoferol (\alpha-TOC).Porphyra 334 isolated from Porphyra leucosticta was studied as an inhibitor of lipid peroxidation in vitro using the β-carotene bleaching technique. The method of decolorization of β-carotene is widely used to determine the antioxidant capacity of various substances in lipophilic medium, most of them extracted from fruits, vegetables and other products intended for food consumption in order to determine their degree of self-preservation in a natural state. In this test, α-tocopherol (α-TOC) was used as a positive control.
Porphyra 334 aislado de Porphyra leucosticta muestra actividad antioxidante moderada a nivel de inhibición de la peroxidación lipídica. Se constituye, pues, como un antioxidante de actividad moderada in vitro.Porphyra 334 isolated from Porphyra leucosticta shows moderate antioxidant activity at the level of lipid peroxidation inhibition. It is thus constituted as an antioxidant of moderate activity in vitro .
El protocolo que se llevó a cabo fue basado en Marklund & Marklund (1974, Eur. j. Biochem., 47: 469-474) con algunas modificaciones. Relaciones de dosis-respuesta para las MAAs objeto de estudio se determinaron a diferentes concentraciones.The protocol that was carried out was based on Marklund & Marklund (1974, Eur. J. Biochem., 47: 469-474) with some modifications. Relations of dose-response for the MAAs under study is determined at different concentrations.
Porphyra 334 aislado de Porphyra leucosticta a concentraciones de 1 mM inhibe al 50% la cinética de oxidación del pirogalol.Porphyra 334 isolated from Porphyra leucosticta at concentrations of 1 mM 50% inhibits the oxidation kinetics of pyrogallol.
Al actuar como antioxidante y secuestrador de radicales libres, este compuesto, en extractos o preparados que lo contengan, podría utilizarse en preparados o formulaciones farmaceúticas para la prevención y el tratamiento terapéutico de enfermedades o afecciones relacionadas con los radicales libres, en productos de parafarmacia, en alimentos funcionales, complementos nutricionales y preparados nutracéuticos, y en la industria alimentaria como potencial antioxidante (aditivo).By acting as an antioxidant and sequestrant of free radicals, this compound, in extracts or preparations that contain, could be used in preparations or formulations Pharmaceuticals for the prevention and therapeutic treatment of diseases or conditions related to free radicals, in parapharmacy products, in functional foods, supplements Nutritional and nutraceutical preparations, and in the industry food as antioxidant potential (additive).
Figura 1. Área (%) de picos eluídos y concentraciones expresadas en mg g^{-1} PS de diferentes MAAs presentes en extractos metanólicos de las algas Porphyra leucosticta, Gymnogongrus devoniensis, Gelidium sesquipedale y del liquen Lichina pygmaea. Se observa la presencia de un tipo de MAA mayoritario en cada organismo (> 66%) junto con otras MAAs minoritarias y trazas de sustancias no identificadas.Figure 1. Area (%) of eluted peaks and concentrations expressed in mg g-1 PS of different MAAs present in methanolic extracts of the algae Porphyra leucosticta , Gymnogongrus devoniensis, Gelidium sesquipedale and lichen Lichina pygmaea . The presence of a type of majority MAA in each organism (> 66%) is observed together with other minor MAAs and traces of unidentified substances.
Figura 2. Cromatogramas de extractos acuosos de MAAs eluidos de la columna cargada con resina DOWEX.Figure 2. Chromatograms of aqueous extracts of MAAs eluted from the column loaded with DOWEX resin.
Figura 3. Tabla . Dosis (\muM) - respuesta de la actividad antioxidante (%) de porphyra 334 aislado de Porphyra leucosticta con respecto a 10 \muM de \alpha-tocoferol por el método de decoloración del \beta-caroteno. Los valores representan los valores medios y desviación estándar de 3 experimentos. Porphyra 334 aislado de Porphyra leucosticta resulta un buen antioxidante a concentración de 100-200 \muM.Figure 3. Table. Dose (µM) - antioxidant activity response (%) of porphyra 334 isolated from Porphyra leucosticta with respect to 10 µM of α-tocopherol by the method of decolorization of β-carotene. The values represent the mean values and standard deviation of 3 experiments. Porphyra 334 isolated from Porphyra leucosticta is a good antioxidant at a concentration of 100-200 µM.
Figura 4. Capacidad de secuestro de radicales superóxido generados por el método del pirogalol de porphyra 334 aislado de Porphyra leucosticta. Se representa la media y desviación estándar de tres experimentos.Figure 4. Sequestration capacity of superoxide radicals generated by the porphyra 334 pyrogallol method isolated from Porphyra leucosticta . The mean and standard deviation of three experiments are represented.
Se ha purificado compuestos del tipo aminoácidos tipo micosporina en fase acuosa partiendo de Porphyra leucosticta. Los compuestos se han detectado y caracterizado por HPLC (Waters 600). La columna empleada para la separación de los MAAs en el HPLC fue una C_{8} (Sphereclone^{TM}, Phenomenex, Aschaffenburg, Alemania), empaquetada con micropartículas porosas de sílica de 5 mm de diámetro con superficie derivatizada con una cadena alifática de 8 átomos de carbono (octadecil silano). Su tamaño era de 250 x 4.6 mm. Se empleó una precolumna (Phenomenex, Aschaffenburg, Alemania) afín a la columna empleada. La fase móvil que se empleó fue metanol al 2.5% (v/v, calidad HPLC) más 0.1% de ácido acético (v/v) bombeada isocráticamente a una velocidad de flujo de 0.5 ml min^{-1}. Se empleó un detector UV-visible (detector de fotodiodos 996), que medía la absorbancia para cada muestra entre los 290 y 400 nm. En la figura 1 vienen recogidos los porcentajes en área de los picos cromatografiados de distintos extractos algales, algunos identificados como MAAs y otros desconocidos. El objetivo de la purificación fue aislar en fase acuosa el MAA mayoritario en Porphyra leucosticta además de eliminar trazas y otro tipos de compuestos no identificados.Compounds of the mycosporin type amino acid type have been purified in the aqueous phase starting from Porphyra leucosticta . The compounds have been detected and characterized by HPLC (Waters 600). The column used for the separation of the MAAs in the HPLC was a C 8 (Sphereclone?, Phenomenex, Aschaffenburg, Germany), packed with porous silica microparticles of 5 mm in diameter with surface derivatized with an aliphatic chain of 8 carbon atoms (octadecyl silane). Its size was 250 x 4.6 mm. A pre-column (Phenomenex, Aschaffenburg, Germany) related to the column used was used. The mobile phase used was 2.5% methanol (v / v, HPLC quality) plus 0.1% acetic acid (v / v) isocratically pumped at a flow rate of 0.5 ml min -1. A UV-visible detector (photodiode detector 996) was used, which measured the absorbance for each sample between 290 and 400 nm. Figure 1 shows the percentages in area of the chromatographed peaks of different algal extracts, some identified as MAAs and others unknown. The objective of the purification was to isolate the major MAA in Porphyra leucosticta in the aqueous phase, in addition to removing traces and other types of unidentified compounds.
Una vez extraído el cromatograma a 330 nm, se identificaron los picos por co-cromatógrafa según sus espectros y tiempos de retención, comparándose con estándares de MAAs, proporcionados por el profesor Dr. Ulf Karsten (Universidad de Rostock, Alemania) extraídos de distintos organismos marinos: Mastocarpus stellatus (shinorine), Porphyra yezoensis (porphyra-334), Bostrychia scorpioides (palythine), los ojos de la trucha del coral Plectropomus leopardus (asterine 330) y el liquen Lichina pygmaea recolectado en Francia (M-glycine). Los cromatogramas de los extractos recogidos después del paso por la columna de intercambio iónico DOWEX50 se muestran en la figura 2. Como se puede observar, en el caso del extracto procedente del alga P. leucosticta, inicialmente con la presencia de 4 MAAs distintas, posteriormente sólo aparecen dos de ellos, porphyra 334 y shinorine, tan semejantes en cuanto a estructura, grupos funcionales y tamaño que su separación resultó realmente difícil. La proporción entre shinorine y porphyra 334 se mantuvo constante a lo largo del proceso de purificación (1: 8.5 aprox.).Once the chromatogram was extracted at 330 nm, the peaks were identified by co-chromatograph according to their spectra and retention times, compared with MAA standards, provided by Professor Dr. Ulf Karsten (University of Rostock, Germany) extracted from different organisms Marine: Mastocarpus stellatus (shinorine), Porphyra yezoensis (porphyra-334), Bostrychia scorpioides (palythine), the eyes of the coral trout Plectropomus leopardus (asterine 330) and the lichen Lichina pygmaea collected in France (M-glycine). The chromatograms of the extracts collected after passing through the DOWEX50 ion exchange column are shown in Figure 2. As can be seen, in the case of the extract from the P. leucosticta algae, initially with the presence of 4 different MAAs, subsequently only two of them appear, porphyra 334 and shinorine, so similar in structure, functional groups and size that their separation was really difficult. The ratio between shinorine and porphyra 334 remained constant throughout the purification process (1: 8.5 approx.).
La extracción a escala preparativa se realizó disolviendo 60-80 g (PF) de material biológico en 1 litro de metanol al 20% v/v e incubándose en un baño termostático a 45°C durante 2 horas. Posteriormente se centrifuga el extracto a 14000 rpm durante 15 min y rotavaporación a 45°C para eliminar parte del metanol de la muestra.Preparatory scale extraction was performed dissolving 60-80 g (PF) of biological material in 1 liter of 20% v / v methanol and incubating in a thermostatic bath to 45 ° C for 2 hours. Subsequently, the extract is centrifuged at 14000 rpm for 15 min and rotary evaporation at 45 ° C to eliminate part of the methanol in the sample.
La purificación se realiza en tres pasos consecutivos en los que se combinan técnicas cromatográficas de absorción mediante la aplicación de carbono activo, precipitación de polisacáridos al añadir a la muestra metanol 100% y separación final mediante cromatografía de intercambio iónico (resina Dowex 50 W x 8-100). Para la elución del aminoácido tipo micosporina porphyra 334 se utilizó como eluyente agua bidestilada, con un pH ligeramente alcalino (7.2). Finalmente se obtuvieron soluciones acuosas de MAA en alto grado de pureza en concentraciones del orden de mM.The purification is done in three steps Consecutive in which chromatographic techniques of absorption by the application of active carbon, precipitation of polysaccharides by adding 100% methanol to the sample and separation final by ion exchange chromatography (Dowex 50 resin W x 8-100). For elution of the amino acid type Mycosporin porphyra 334 was used as eluent double-distilled water, with a slightly alkaline pH (7.2). They were finally obtained aqueous solutions of MAA in high degree of purity in concentrations of the order of mM.
Para medir la actividad como secuestradores de radicales hidrosolubles se ha utilizado el método de la ABTS peroxidasa, el cual permite determinar la actividad antioxidante total (TAA) de una muestra entendida como un parámetro que permite cuantificar la capacidad de una muestra, natural o procesada, de secuestrar radicales libres presentes en una solución acuosa. Este parámetro está orientado a dar información de la actividad antioxidante que puede presentar una muestra concreta con independencia de las actividades parciales que puedan presentar cada uno de sus componentes o los efectos de sinergismo que pudiesen establecerse.To measure activity as kidnappers of water-soluble radicals the ABTS method has been used peroxidase, which allows to determine the antioxidant activity total (TAA) of a sample understood as a parameter that allows quantify the capacity of a sample, natural or processed, of sequester free radicals present in an aqueous solution. This parameter is oriented to give activity information antioxidant that can present a specific sample with independence of the partial activities that each one of its components or the effects of synergism that could settle.
El 2,2'-Azino-bis-(3-etil-benzotiazolina-6-ácido sulfónico) o ABTS es un compuesto que presenta gran estabilidad química, alta solubilidad en agua y un máximo de absorción en la banda del UVA a 342 nm. Este compuesto en presencia de H_{2}O_{2} y enzimas peroxidasas deriva a un radical metaestable (ABTS^{+}) con un espectro de absorción característico y diferente al ABTS, presentando máximos de absorción en la región espectral del UV y visible a 413, 645, 727 y 811 nm.He 2,2'-Azino-bis- (3-ethyl-benzothiazoline-6-acid sulfonic) or ABTS is a compound that has great stability chemical, high water solubility and maximum absorption in the UVA band at 342 nm. This compound in the presence of H 2 O 2 and peroxidases enzymes derive to a radical metastable (ABTS +) with a characteristic absorption spectrum and different from ABTS, presenting maximum absorption in the region UV spectral and visible at 413, 645, 727 and 811 nm.
El ABTS es un producto que presenta gran estabilidad en un amplio rango de pH, mostrando el mismo espectro de absorbancia a pH 4 y pH 8.5. Así mismo, la formación del radical ABTS^{+} también se lleva a cabo en ese rango de pH pero la actividad enzimática de la peroxidasa sí que es dependiente del pH del medio de reacción de manera que al alcalinizarse éste la actividad disminuye, aumentando así el periodo de retardo o "lag time". La actividad de nuestra enzima se podría ajustar a una curva exponencial de manera que es máxima a pH 4.5 y deja de ser activa a pH superiores a 10. Nuestros ensayos discurrirán a pH 6-8.5 de manera que aseguramos la actividad de la enzima.ABTS is a product that presents great stability over a wide pH range, showing the same spectrum of absorbance at pH 4 and pH 8.5. Likewise, the formation of the radical ABTS + is also carried out in that pH range but the enzymatic activity of peroxidase itself that is pH dependent of the reaction medium so that upon alkalization it the activity decreases, thus increasing the delay period or "lag time ". The activity of our enzyme could be adjusted to a exponential curve so that it is maximum at pH 4.5 and ceases to be active at pH higher than 10. Our tests will run at pH 6-8.5 so that we ensure the activity of the enzyme.
La cuantificación de la capacidad de secuestro de radicales libres de una muestra se llevan a cabo mediante ensayos de decoloración en los cuales la formación de ABTS^{+} da lugar a una coloración característica que disminuirá de manera proporcional a la cantidad de sustancias con capacidad de atrapar estos radicales que se le añadan al volumen de reacción. Esta pérdida de color puede medirse mediante seguimientos cinéticos de pérdida de absorbancia a 413 nm (longitud de onda que no interfiere con otras moléculas) a lo largo de un minuto utilizando como peroxidasa la HRP y como control negativo el ácido ascórbico (L-ASC). El medio de reacción se compone de tampón fosfato 50 mM pH 6, 7.5, 8, H_{2}O_{2} 2 mM, ABTS 2 mM, enzima HRP 0.25 \muM y muestra a concentraciones crecientes.The quantification of kidnapping capacity Free radicals of a sample are carried out by bleaching assays in which the formation of ABTS + gives place to a characteristic coloration that will decrease so proportional to the amount of substances capable of trapping these radicals that are added to the reaction volume. This Color loss can be measured by kinetic tracking of loss of absorbance at 413 nm (wavelength that does not interfere with other molecules) over a minute using as peroxidase HRP and as a negative control ascorbic acid (THE C). The reaction medium is composed of buffer 50 mM phosphate pH 6, 7.5, 8, 2 mM H2O2, 2 mM ABTS, enzyme 0.25 µM HRP and sample at increasing concentrations.
El cálculo de TAA se establece según la relación entre las pendientes (Abs/min) de ensayos enzimáticos en los cuales el curso de la reacción es estimado en ausencia de antioxidantes (control positivo), y en presencia de diferentes concentraciones de sustancias con posible actividad antioxidante. De este modo, la pendiente de la cinética control correspondería a una TAA del cero por ciento, calculándose en base a ésta los porcentajes de inhibición de las demás curvas.The calculation of TAA is established according to the relationship between the slopes (Abs / min) of enzymatic assays in which The course of the reaction is estimated in the absence of antioxidants (positive control), and in the presence of different concentrations of substances with possible antioxidant activity. In this way, the pending kinetic control would correspond to a TAA of zero percent, calculating based on this the percentages of inhibition of the other curves.
La peroxidación lipídica es un mecanismo bien establecido de daño celular en plantas y animales, así como de deterioro de alimentos (enranciamiento). Este proceso conduce a la producción de peróxidos lipídicos y aldehídos de degradación que conlleva pérdida de la función de la membrana celular y de su integridad. Porphyra 334 aislado de Porphyra leucosticta se estudió como inhibidor de la peroxidación lipídica in vitro mediante la técnica de decoloración del \beta-caroteno.Lipid peroxidation is a well-established mechanism of cell damage in plants and animals, as well as food spoilage (thickening). This process leads to the production of lipid peroxides and degradation aldehydes that leads to loss of cell membrane function and integrity. Porphyra 334 isolated from Porphyra leucosticta was studied as an inhibitor of lipid peroxidation in vitro using the β-carotene bleaching technique.
El método de decoloración del \beta-caroteno es ampliamente utilizado para la determinación de la capacidad antioxidante de diversas sustancias en medio lipofílico, la mayoría de ellas extraídas de frutas, vegetales y demás productos destinados a consumo alimentario para poder determinar su mayor o menor grado de autoconservación en estado natural. Se trata de un método espectrofotométrico que mide la inhibición que causa un antioxidante sobre la decoloración del \beta-caroteno en un sistema acuoso emulsificado con Tween 20 y ácido linoleico.The method of fading β-carotene is widely used for Determination of the antioxidant capacity of various substances in lipophilic medium, most of them extracted from fruits, vegetables and other products intended for food consumption for be able to determine its greater or lesser degree of self-preservation in natural state. It is a spectrophotometric method that measures the inhibition that an antioxidant causes on the discoloration of the β-carotene in an emulsified aqueous system with Tween 20 and linoleic acid.
El ácido linoleico se autoxida a una alta velocidad ante la presencia de átomos de hidrógeno especialmente activados. El \beta-caroteno, precursor de la vitamina A, también es conocido como antioxidante lipofílico que previene de la peroxidación lipídica en membranas secuestrando moléculas de oxígeno singlete y radicales lipídicos peroxilos. El \beta-caroteno, cuando se encuentra en presencia de ácido linoleico, cede electrones retardando la etapa de iniciación del proceso de autooxidación del ácido linoleico así como limitando la fase de propagación del daño al eliminar simultáneamente radicales peróxidos formados. Si añadimos una nueva sustancia con posible capacidad antioxidante al medio de reacción que contiene ácido linoleico y \beta-caroteno, ésta nueva sustancia tenderá a oxidarse ella preferentemente al \beta-caroteno, compitiendo con este por el secuestro de estos radicales.Linoleic acid self-oxidizes at high velocity in the presence of hydrogen atoms especially activated Β-carotene, precursor of the Vitamin A, is also known as lipophilic antioxidant that prevents lipid peroxidation in sequestering membranes singlet oxygen molecules and peroxyl lipid radicals. He β-carotene, when in presence of linoleic acid, yields electrons delaying the stage of initiation of the linoleic acid autooxidation process as well as limiting the propagation phase of damage by eliminating simultaneously formed peroxide radicals. If we add a new one substance with possible antioxidant capacity to the reaction medium which contains linoleic acid and β-carotene, this new substance will tend to oxidize it preferably at β-carotene, competing with this for the kidnapping of these radicals.
El \beta-caroteno presenta un máximo de absorción a 470 nm. Este máximo varía cuando la molécula se oxida ya que pierde dobles enlaces y la estructura del cromóforo de la molécula se ve alterada, perdiendo así su característico color naranja y pudiendo ser detectado espectrofotométricamente. La absorbancia del medio de reacción permanecerá invariable a lo largo del tiempo en presencia de sustancias antioxidantes, advirtiéndose una caída en la absorbancia de la muestra cuando se mida en ausencia de antioxidantes. Así pues, la medida de la capacidad antioxidante de una sustancia será inversamente proporcional a la caída de pendiente de la curva que describe la oxidación del \beta-caroteno (medida a longitud de onda de 470 nm).Β-carotene has a maximum absorption at 470 nm. This maximum varies when the molecule it oxidizes because it loses double bonds and the chromophore structure of the molecule is altered, thus losing its characteristic Orange color and can be detected spectrophotometrically. The absorbance of the reaction medium will remain unchanged throughout of time in the presence of antioxidant substances, warning a drop in the absorbance of the sample when measured in the absence of antioxidants Thus, the measure of antioxidant capacity of a substance will be inversely proportional to the fall of slope of the curve that describes the oxidation of β-carotene (measured at 470 wavelength nm).
En este ensayo, como control positivo se utilizó el \alpha-tocoferol (\alpha-TOC).In this trial, a positive control was used the α-tocopherol (α-TOC).
La actividad de la solución se evaluó según el grado de decoloración del \beta-caroteno, aplicando la fórmula propuesta por Hidalgo y colaboradores (1994, Phytochemistry, 37: 1585-1587) con algunas modificaciones:The activity of the solution was evaluated according to the degree of discoloration of β-carotene, applying the formula proposed by Hidalgo et al. (1994, Phytochemistry, 37: 1585-1587) with some modifications:
AA = [P\ muestra - P\ control/P\ Patrón - P\ control] \cdot 100AA = [P \ Sample - P \ control / P \ Pattern - P \ control] \ cdot 100
\newpage\ newpage
P hace referencia a las pendientes de las curvas de decoloración obtenidas (Abs/tiempo). Para ello ajustamos mediante regresión lineal la parte de la curva cinética que describe un comportamiento lineal. Los coeficientes de correlación para cada réplica de cada muestra eran todos superiores a 0.98.P refers to the slopes of the curves of discoloration obtained (Abs / time). For this we adjust by linear regression the part of the kinetic curve that describes linear behavior The correlation coefficients for each Replica of each sample were all greater than 0.98.
Los radicales superóxidos (O_{2}^{-}) son mediadores de reacciones de autooxidación de algunos compuestos. La mayoría de las veces estos compuestos oxidados se caracterizan por poseer un espectro de absorción característico y cuantificable por espectrofotometría.The superoxide radicals (O2 -) are mediators of autooxidation reactions of some compounds. The most of the time these oxidized compounds are characterized by have a characteristic and quantifiable absorption spectrum by spectrophotometry
El pirogalol (1,2,3-benzenotriol) es una sustancia que se autooxida rápidamente en presencia de oxígeno especialmente en soluciones alcalinas. A pH 7.9 la SOD inhibe el 99% de la reacción indicando una participación prácticamente total del anión superóxido O_{2}^{-} en la reacción. El pirogalol oxidado presenta un máximo de absorción a 420 nm de manera que la capacidad de las MAAs para secuestrar radicales superóxido fue medida como pérdida de absorbancia de ensayos cinéticos monitorizados espectrofotométricamente (Shimadzu UV 1603) durante un minuto de reacción. El protocolo que se llevó a cabo fue basado en Marklund & Marklund (1974, Eur. J. Biochem., 47: 469-474) con algunas modificaciones. La mezcla reacción contenía 0.4 mM de pirogalol y el MAA a diferentes concentraciones en 50 mM de tampón fosfato a pH 8.2, conteniendo 1 mM de ácido dietilenotriaminopentaacético en un volumen final de incubación de 1 ml. La temperatura se mantuvo estable a 20 \pm 1°C. El control positivo fue la curva cinética de generación de radicales de pirogalol oxidado en ausencia de antioxidantes para compararlos con distintas concentraciones de SOD como antioxidante conocido. Relaciones de dosis-respuesta para las MAAs objeto de estudio se determinaron a diferentes concentraciones. La capacidad de secuestro de radicales superóxido de los extractos purificados se evaluó siguiendo la siguiente fórmula:Pyrogallol (1,2,3-benzenotriol) is a substance that is autooxidizes rapidly in the presence of oxygen especially in alkaline solutions At pH 7.9 SOD inhibits 99% of the reaction indicating a practically total participation of the superoxide anion O 2 - in the reaction. Oxidized pyrogallol has a maximum absorption at 420 nm so that the capacity of the MAAs to sequester superoxide radicals was measured as loss of absorbance of monitored kinetic assays spectrophotometrically (Shimadzu UV 1603) for one minute of reaction. The protocol that was carried out was based on Marklund & Marklund (1974, Eur. J. Biochem., 47: 469-474) with some modifications. Mix reaction contained 0.4 mM pyrogallol and MAA at different 50 mM concentrations of phosphate buffer at pH 8.2, containing 1 mM of diethylenetriaminepentaacetic acid in a final volume of 1 ml incubation. The temperature was stable at 20 ± 1 ° C The positive control was the kinetic curve of generating oxidized pyrogallol radicals in the absence of antioxidants for compare them with different concentrations of SOD as an antioxidant known. Dose-response relationships for MAAs under study were determined at different concentrations. The ability to sequester superoxide radicals of the purified extracts was evaluated following the following formula:
AA = 100 - [P\ muestra \cdot 100/P\ control]AA = 100 - [P \ sample \ cdot 100 / P \ control]
P hace referencia a las pendientes de las curvas cinéticas de oxidación del pirogalol (Abs/tiempo).P refers to the slopes of the curves oxidation kinetics of pyrogallol (Abs / time).
Claims (2)
Priority Applications (7)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
ES200702944A ES2301434B1 (en) | 2005-08-31 | 2005-08-31 | USE OF AMINO ACID TYPE MICOSPORINE (PORFINE 334) IN PRODUCTS FOR PREVENTION OF CATARATES. |
ES200702946A ES2301436B1 (en) | 2005-08-31 | 2005-08-31 | USE OF MICOSPORINE TYPE AMINO ACID (PORFIRA 334) AS AN ANTIOXIDANT OR ADDITIVE IN FOOD PRODUCTS. |
ES200702945A ES2301435B1 (en) | 2005-08-31 | 2005-08-31 | USE OF MICROSPORINE TYPE AMINO ACID (PORFIRA 334) IN PRODUCTS FOR PREVENTION AND TREATMENT OF ACTINIC ERYTHEMA, PHOTOCARCINOGENESIS AND PHOTO AGING. |
ES200502161A ES2301293B1 (en) | 2005-08-31 | 2005-08-31 | USE OF MICOSPORINE TYPE AMINO ACID (PORPHYRA 334) AS AN ANTIOXIDANT. |
ES200702943A ES2301433A1 (en) | 2005-08-31 | 2005-08-31 | Use of a mycosporin-type amino acid (porphyra 334) as an antioxidant |
ES200702947A ES2301437B1 (en) | 2005-08-31 | 2005-08-31 | USE OF MICOSPORINE TYPE AMINO ACIDS (PORFIRA 334) IN THE PREVENTION OF OXIDATION OF COSMETIC AND PHARMACEUTICAL PRODUCTS. |
PCT/ES2006/000488 WO2007026035A2 (en) | 2005-08-31 | 2006-08-28 | Use of a mycosporin-type amino acid (porphyra 334) as an antioxidant |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
ES200502161A ES2301293B1 (en) | 2005-08-31 | 2005-08-31 | USE OF MICOSPORINE TYPE AMINO ACID (PORPHYRA 334) AS AN ANTIOXIDANT. |
Publications (2)
Publication Number | Publication Date |
---|---|
ES2301293A1 ES2301293A1 (en) | 2008-06-16 |
ES2301293B1 true ES2301293B1 (en) | 2009-05-01 |
Family
ID=37809229
Family Applications (6)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ES200702946A Active ES2301436B1 (en) | 2005-08-31 | 2005-08-31 | USE OF MICOSPORINE TYPE AMINO ACID (PORFIRA 334) AS AN ANTIOXIDANT OR ADDITIVE IN FOOD PRODUCTS. |
ES200702947A Active ES2301437B1 (en) | 2005-08-31 | 2005-08-31 | USE OF MICOSPORINE TYPE AMINO ACIDS (PORFIRA 334) IN THE PREVENTION OF OXIDATION OF COSMETIC AND PHARMACEUTICAL PRODUCTS. |
ES200702944A Active ES2301434B1 (en) | 2005-08-31 | 2005-08-31 | USE OF AMINO ACID TYPE MICOSPORINE (PORFINE 334) IN PRODUCTS FOR PREVENTION OF CATARATES. |
ES200502161A Active ES2301293B1 (en) | 2005-08-31 | 2005-08-31 | USE OF MICOSPORINE TYPE AMINO ACID (PORPHYRA 334) AS AN ANTIOXIDANT. |
ES200702945A Active ES2301435B1 (en) | 2005-08-31 | 2005-08-31 | USE OF MICROSPORINE TYPE AMINO ACID (PORFIRA 334) IN PRODUCTS FOR PREVENTION AND TREATMENT OF ACTINIC ERYTHEMA, PHOTOCARCINOGENESIS AND PHOTO AGING. |
ES200702943A Pending ES2301433A1 (en) | 2005-08-31 | 2005-08-31 | Use of a mycosporin-type amino acid (porphyra 334) as an antioxidant |
Family Applications Before (3)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ES200702946A Active ES2301436B1 (en) | 2005-08-31 | 2005-08-31 | USE OF MICOSPORINE TYPE AMINO ACID (PORFIRA 334) AS AN ANTIOXIDANT OR ADDITIVE IN FOOD PRODUCTS. |
ES200702947A Active ES2301437B1 (en) | 2005-08-31 | 2005-08-31 | USE OF MICOSPORINE TYPE AMINO ACIDS (PORFIRA 334) IN THE PREVENTION OF OXIDATION OF COSMETIC AND PHARMACEUTICAL PRODUCTS. |
ES200702944A Active ES2301434B1 (en) | 2005-08-31 | 2005-08-31 | USE OF AMINO ACID TYPE MICOSPORINE (PORFINE 334) IN PRODUCTS FOR PREVENTION OF CATARATES. |
Family Applications After (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ES200702945A Active ES2301435B1 (en) | 2005-08-31 | 2005-08-31 | USE OF MICROSPORINE TYPE AMINO ACID (PORFIRA 334) IN PRODUCTS FOR PREVENTION AND TREATMENT OF ACTINIC ERYTHEMA, PHOTOCARCINOGENESIS AND PHOTO AGING. |
ES200702943A Pending ES2301433A1 (en) | 2005-08-31 | 2005-08-31 | Use of a mycosporin-type amino acid (porphyra 334) as an antioxidant |
Country Status (2)
Country | Link |
---|---|
ES (6) | ES2301436B1 (en) |
WO (1) | WO2007026035A2 (en) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ES2317741B1 (en) * | 2006-06-20 | 2010-02-10 | Universidad De Malaga | COMPOSITION FOR SOLAR PROTECTION BASED ON ALGAE AND LIQUEN EXTRACTS. |
KR102196422B1 (en) * | 2019-07-15 | 2020-12-30 | 주식회사 바이오에프디엔씨 | Method of cell reprogramming adult cell to induced pluripotent stem cell using Porphyra334 |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2655268B1 (en) * | 1989-12-06 | 1994-10-14 | Secma | USE OF ALGAE EXTRACTS FOR THE PREPARATION OF PHARMACEUTICAL, COSMETIC, FOOD OR AGRICULTURAL COMPOSITIONS. |
CA2251457A1 (en) * | 1998-10-23 | 2000-04-23 | Norman Huner | Compositions including naturally occurring compounds from plants, algae and cyanobacteria for protection against solar radiation |
FR2803201B1 (en) * | 1999-12-30 | 2004-11-26 | Gelyma | ALGAE EXTRACT WITH FILTERING ACTIVITY WITH RESPECT TO ULTRAVIOLET RADIATION |
GB0028161D0 (en) * | 2000-11-17 | 2001-01-03 | Natural Environment Res | Personal care compositions |
WO2003041679A2 (en) * | 2001-11-14 | 2003-05-22 | Larena | Product containing a red alga extract of the genus porphyra and uses thereof for protecting cells |
FR2882894B1 (en) * | 2005-03-11 | 2009-04-03 | Larena Sa | SUPPLETIVE FOOD COMPOSITION |
-
2005
- 2005-08-31 ES ES200702946A patent/ES2301436B1/en active Active
- 2005-08-31 ES ES200702947A patent/ES2301437B1/en active Active
- 2005-08-31 ES ES200702944A patent/ES2301434B1/en active Active
- 2005-08-31 ES ES200502161A patent/ES2301293B1/en active Active
- 2005-08-31 ES ES200702945A patent/ES2301435B1/en active Active
- 2005-08-31 ES ES200702943A patent/ES2301433A1/en active Pending
-
2006
- 2006-08-28 WO PCT/ES2006/000488 patent/WO2007026035A2/en active Application Filing
Non-Patent Citations (1)
Title |
---|
GRÖNIGER et al. Photoprotective compounds in cyanobacteria, phytoplancton and macroalgae- a database. Journal of Phytochemistry and Photobiology B. Biology, 2000, vol. 58, páginas 115-122. * |
Also Published As
Publication number | Publication date |
---|---|
ES2301437A1 (en) | 2008-06-16 |
ES2301434B1 (en) | 2009-05-01 |
ES2301436B1 (en) | 2009-05-08 |
ES2301433A1 (en) | 2008-06-16 |
ES2301434A1 (en) | 2008-06-16 |
WO2007026035A3 (en) | 2007-05-10 |
ES2301293A1 (en) | 2008-06-16 |
ES2301436A1 (en) | 2008-06-16 |
WO2007026035A2 (en) | 2007-03-08 |
ES2301437B1 (en) | 2009-05-01 |
ES2301435B1 (en) | 2009-05-01 |
ES2301435A1 (en) | 2008-06-16 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
De la Coba et al. | Antioxidant activity of mycosporine-like amino acids isolated from three red macroalgae and one marine lichen | |
Vinayagam et al. | Antioxidant activity of methanolic extracts of leaves and flowers of Nerium indicum | |
Lee et al. | Antioxidant properties of tidal pool microalgae, Halochlorococcum porphyrae and Oltamannsiellopsis unicellularis from Jeju Island, Korea | |
ES2301293B1 (en) | USE OF MICOSPORINE TYPE AMINO ACID (PORPHYRA 334) AS AN ANTIOXIDANT. | |
ES2301294B1 (en) | USE OF MICOSPORINE TYPE AMINO ACID (M-GLY) IN PRODUCTS FOR PREVENTION AND TREATMENT OF ACTINIC ERYTHEMA, PHOTOCARCINOGENESIS AND PHOTO AGING. | |
ES2301426B1 (en) | USE OF MICROSPORINE TYPE AMINO ACID (SHIRORINE) IN PRODUCTS FOR PREVENTION AND TREATMENT OF ACTINIC ERYTHEMA, PHOTOCARCINOGENESIS AND PHOTO AGING. | |
ES2307438B1 (en) | USE OF A PURIFIED MIXTURE OF MICOSPORINE TYPES AMINO ACIDS (ASTERINE 330 + PALITINE) IN THE PREVENTION OF OXIDATION OF COSMETIC AND PHARMACEUTICAL PRODUCTS. | |
이주희 | Antioxidant Potential of Sargassum horneri Ethanol Extract against Urban Particulate Matter Induced Oxidation | |
Seo et al. | Antioxidant and Xanthine Oxidase Inhibition Activities of Cynomorium songaricum Extracts | |
Kernel | Some Bioactive Compounds and Antioxidant Activities of the Bitter | |
Moses Richardson | Antioxidant and cytotoxic investigations of Beta vulgaris L/Jaime Stella a/p Moses Richardson | |
KR20120108139A (en) | Compositions for antioxidation comprising extract of agarum clathratum |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
EC2A | Search report published |
Date of ref document: 20080616 Kind code of ref document: A1 |